Nesiritide Use Following Cardiac Surgery in Infants

Stopped early · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Heart Defects, Congenital, Cardiopulmonary Bypass

In brief

The purpose of this study is to determine the effects of nesiritide on urine output and hemodynamics following cardiopulmonary bypass in infants. Safety and pharmacokinetic data will also be obtained.

Key facts

Study ID

NCT00281671

Run by

Boston Children's Hospital

People needed

9

Starts

2006-04-08

Expected to finish

2008-10-01

Last updated by the study team

2020-08-27

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 48 hours after cardiac surgery requiring cardiopulmonary bypass
• < 1 year of age
• Receiving chlorothiazide and furosemide for > 12 hours
• Urine output < 4 cc/kg/hour, or fluid intake > output for 2 consecutive days
• Receiving mechanical ventilation
• Presence of body wall edema on CXR, defined as a radiologic index of > 2
• Plan for > 24 hrs further diuresis before chest closure or extubation

You may not qualify if…

• Age > 365 days at the time of enrollment
• Corrected estimated gestational age < 35 weeks at the time of enrollment
• Serum creatinine > 2.0 mg/dL at the time of enrollment
• Significant hemodynamic instability at the time of enrollment
• Lack of dedicated intravenous access for nesiritide infusion
• Lack of arterial line for continuous blood pressure monitoring
• Lack of a Foley catheter for continuous urine collection
• Enrollment in another research study such that the outcomes of either study may be confounded by participation in this study, or such that the amount of blood drawn for research purposes becomes excessive.

Where it is running

• Children's Hospital Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.